A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance

Molecular Microbiology

Volumn 43, Issue 5, 2002, Pages 1197-1214

  De Micheli, Michelle ^a   Bille, Jacques ^a   Schueller, Christoph ^b   Sanglard, Dominique ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b University and Biocenter of Vienna   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ANTIFUNGAL AGENT; ESTRADIOL; PYRROLE;

ARTICLE; CANDIDA ALBICANS; CDR1 GENE; CDR2 GENE; CONTROLLED STUDY; DATA BASE; EUKARYOTE; FUNGAL GENE; GENE INDUCTION; GENE SEQUENCE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY SEQUENCE;

ANTIFUNGAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; CANDIDA ALBICANS; DRUG RESISTANCE, FUNGAL; ESTRADIOL; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA;

CANDIDA; CANDIDA ALBICANS; EUKARYOTA;

EID: 0036223414     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2958.2002.02814.x     Document Type: Article

References (45)

1. Synergistic action of GA-binding protein and glucocorticoid receptor in transcription from the mouse mammary tumor virus promoter
2. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole
3. Cloning and expression of Candida albicans ADE2 and proteinase genes on a replicative plasmid in C. albicans and in Saccharomyces cerevisiae
4. Molecular and phenotypic characterization of yeast PDR1 mutants that show hyperactive transcription of various ABC multidrug transporter genes
5. Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis
6. Positive autoregulation of the yeast transcription factor Pdr3p, which is involved in control of drug resistance
7. Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants
8. Mutations in the yeast PDR3, PDR4, PDR7 and PDR9 pleiotropic (multiple) drug resistance loci affect the transcript level of an ATP binding cassette transporter encoding gene PDR5
9. Isogenic strain construction and gene mapping in Candida albicans
10. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains
11. Regulation of transcription factor Pdr1p function by an Hsp70 protein in Saccharomyces cerevisiae
12. Techniques for transformation of E. coli
13. Induced expression of the Candida albicans multidrug resistance gene CDR1 in response to fluconazole and other antifungals
14. Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans
15. Genetic analysis of azole resistance in the Darlington strain of Candida albicans
16. Transcriptional control of the yeast PDR5 gene by the PDR3 gene product
17. Multiple Pdr1p/Pdr3p binding sites are essential for normal expression of the ATP binding cassette transporter protein-encoding gene PDR5
18. Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p
19. Expression of CDR1, a multidrug resistance gene of Candida albicans: Transcriptional activation by heat shock, drugs and human steroid hormones
20. Characterisation of human steroid hormone transport mediated by Cdr1p, a multidrug transporter of Candida albicans, belonging to the ATP binding cassette super family
21. Loss of function mutation in the yeast multiple drug resistance gene PDR5 causes a reduction in chloramphenicol efflux
22. Distinct patterns of gene expression associated with the development of fluconazole resistance in serial Candida albicans isolates from HIV-infected patients with oropharyngeal candidiasis
23. Interaction of the yeast pleiotropic drug resistance genes PDR1 and PDR5
24. Sequential gene disruption in Candida albicans by FLP-mediated site-specific recombination
25. The changing face of candidemia - Emergence of non-Candida albicans species and antifungal resistance
26. 17-Beta-estradiol upregulates the stress response in Candida albicans: Implications for microbial virulence
27. Resistant candidiasis
28. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals
29. CDR1, a multidrug resistance gene from Candida albicans, contains multiple regulatory domains in its promoter and the distal AP-1 element mediates its induction by miconazole
30. Camptothecin sensitivity is mediated by the pleiotropic drug resistance network in yeast
31. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
32. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors
33. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterization of CDR2, a new multidrug ABC transporter gene
34. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents
35. Multiple mechanisms to azole antifungals in yeast
36. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents
37. Comparative amino acid sequence analysis of the C6 zinc cluster family of transcriptional regulators
38. 'White-opaque transition': A second high-frequency switching system in Candida albicans
39. The sea pansy Renilla reniformis luciferase serves as a sensitive bioluminescent reporter for differential gene expression in Candida albicans
40. EFG1 null mutants of Candida albicans switch but cannot express the complete phenotype of white-phase budding cells
41. Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae
42. Evolution of a fungal regulatory gene family: The Zn(II)2Cys6 binuclear cluster DNA binding motif
43. Increased mRNA levels of ERG16, CDR, and MDR1 correlates with increased resistance in azole resistance in Candida albicans isolates from patients infected with human immunodeficiency virus
44. Three distinct secreted aspartyl proteinases in Candida albicans
45. The yeast ATP binding cassette (ABC) protein genes PDR10 and PDR15 are novel targets for the Pdr1 and Pdr3 transcriptional regulators